Tinoridine

DB13001

small molecule investigational

Deskripsi

Tinoridine is under investigation in clinical trial NCT01224756 (Efficacy of Tinoridine in Treating Pain and Inflammation in Adults).

Struktur Molekul 2D

Berat 316.42
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1386 Data
Amlodipine Tinoridine may decrease the antihypertensive activities of Amlodipine.
Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Tinoridine.
Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Tinoridine.
Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Tinoridine.
Isoetharine The risk or severity of hypertension can be increased when Isoetharine is combined with Tinoridine.
Ziprasidone The risk or severity of hypertension can be increased when Ziprasidone is combined with Tinoridine.
Methysergide The risk or severity of hypertension can be increased when Methysergide is combined with Tinoridine.
Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Tinoridine.
Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Tinoridine.
Dihydroergotamine The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Tinoridine.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Tinoridine.
Norepinephrine The risk or severity of hypertension can be increased when Norepinephrine is combined with Tinoridine.
Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Tinoridine.
Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Tinoridine.
Phenylpropanolamine The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Tinoridine.
Promazine The risk or severity of hypertension can be increased when Promazine is combined with Tinoridine.
Droperidol The risk or severity of hypertension can be increased when Droperidol is combined with Tinoridine.
Doxapram The risk or severity of hypertension can be increased when Doxapram is combined with Tinoridine.
Atropine The risk or severity of hypertension can be increased when Atropine is combined with Tinoridine.
Lisuride The risk or severity of hypertension can be increased when Lisuride is combined with Tinoridine.
Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Tinoridine.
Metaraminol The risk or severity of hypertension can be increased when Metaraminol is combined with Tinoridine.
Furazolidone The risk or severity of hypertension can be increased when Furazolidone is combined with Tinoridine.
Epinephrine The risk or severity of hypertension can be increased when Epinephrine is combined with Tinoridine.
Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Tinoridine.
Ergotamine The risk or severity of hypertension can be increased when Ergotamine is combined with Tinoridine.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Tinoridine.
Sufentanil The risk or severity of hypertension can be increased when Sufentanil is combined with Tinoridine.
Methoxamine The risk or severity of hypertension can be increased when Methoxamine is combined with Tinoridine.
Risperidone The risk or severity of hypertension can be increased when Risperidone is combined with Tinoridine.
Tranylcypromine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Tinoridine.
Isoflurane The risk or severity of hypertension can be increased when Isoflurane is combined with Tinoridine.
Propiomazine The risk or severity of hypertension can be increased when Propiomazine is combined with Tinoridine.
Alfentanil The risk or severity of hypertension can be increased when Alfentanil is combined with Tinoridine.
Minaprine The risk or severity of hypertension can be increased when Minaprine is combined with Tinoridine.
Orciprenaline The risk or severity of hypertension can be increased when Orciprenaline is combined with Tinoridine.
Propofol The risk or severity of hypertension can be increased when Propofol is combined with Tinoridine.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Tinoridine.
Trifluoperazine The risk or severity of hypertension can be increased when Trifluoperazine is combined with Tinoridine.
Pseudoephedrine The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Tinoridine.
Benzphetamine The risk or severity of hypertension can be increased when Benzphetamine is combined with Tinoridine.
Ritodrine The risk or severity of hypertension can be increased when Ritodrine is combined with Tinoridine.
Flupentixol The risk or severity of hypertension can be increased when Flupentixol is combined with Tinoridine.
Remifentanil The risk or severity of hypertension can be increased when Remifentanil is combined with Tinoridine.
Bitolterol The risk or severity of hypertension can be increased when Bitolterol is combined with Tinoridine.
Oxymetazoline The risk or severity of hypertension can be increased when Oxymetazoline is combined with Tinoridine.
Diethylpropion The risk or severity of hypertension can be increased when Diethylpropion is combined with Tinoridine.
Salmeterol The risk or severity of hypertension can be increased when Salmeterol is combined with Tinoridine.
Naratriptan The risk or severity of hypertension can be increased when Naratriptan is combined with Tinoridine.
Formoterol The risk or severity of hypertension can be increased when Formoterol is combined with Tinoridine.
Frovatriptan The risk or severity of hypertension can be increased when Frovatriptan is combined with Tinoridine.
Methoxyflurane The risk or severity of hypertension can be increased when Methoxyflurane is combined with Tinoridine.
Selegiline The risk or severity of hypertension can be increased when Selegiline is combined with Tinoridine.
Ergoloid mesylate The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Tinoridine.
Isoprenaline The risk or severity of hypertension can be increased when Isoprenaline is combined with Tinoridine.
Arbutamine The risk or severity of hypertension can be increased when Arbutamine is combined with Tinoridine.
Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Tinoridine.
Halothane The risk or severity of hypertension can be increased when Halothane is combined with Tinoridine.
Moclobemide The risk or severity of hypertension can be increased when Moclobemide is combined with Tinoridine.
Pergolide The risk or severity of hypertension can be increased when Pergolide is combined with Tinoridine.
Desflurane The risk or severity of hypertension can be increased when Desflurane is combined with Tinoridine.
Bromocriptine The risk or severity of hypertension can be increased when Bromocriptine is combined with Tinoridine.
Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Tinoridine.
Aripiprazole The risk or severity of hypertension can be increased when Aripiprazole is combined with Tinoridine.
Isocarboxazid The risk or severity of hypertension can be increased when Isocarboxazid is combined with Tinoridine.
Ergometrine The risk or severity of hypertension can be increased when Ergometrine is combined with Tinoridine.
Lisdexamfetamine The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Tinoridine.
Fenoterol The risk or severity of hypertension can be increased when Fenoterol is combined with Tinoridine.
Pirbuterol The risk or severity of hypertension can be increased when Pirbuterol is combined with Tinoridine.
Ephedra sinica root The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Tinoridine.
Ephedrine The risk or severity of hypertension can be increased when Ephedrine is combined with Tinoridine.
Mephentermine The risk or severity of hypertension can be increased when Mephentermine is combined with Tinoridine.
Procaterol The risk or severity of hypertension can be increased when Procaterol is combined with Tinoridine.
Yohimbine The risk or severity of hypertension can be increased when Yohimbine is combined with Tinoridine.
Methotrimeprazine The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Tinoridine.
Clenbuterol The risk or severity of hypertension can be increased when Clenbuterol is combined with Tinoridine.
Bambuterol The risk or severity of hypertension can be increased when Bambuterol is combined with Tinoridine.
MMDA The risk or severity of hypertension can be increased when MMDA is combined with Tinoridine.
Midomafetamine The risk or severity of hypertension can be increased when Midomafetamine is combined with Tinoridine.
2,5-Dimethoxy-4-ethylamphetamine The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Tinoridine.
4-Methoxyamphetamine The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Tinoridine.
4-Bromo-2,5-dimethoxyamphetamine The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Tinoridine.
Tenamfetamine The risk or severity of hypertension can be increased when Tenamfetamine is combined with Tinoridine.
Chlorphentermine The risk or severity of hypertension can be increased when Chlorphentermine is combined with Tinoridine.
Dextroamphetamine The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Tinoridine.
Phendimetrazine The risk or severity of hypertension can be increased when Phendimetrazine is combined with Tinoridine.
Solifenacin The risk or severity of hypertension can be increased when Solifenacin is combined with Tinoridine.
Periciazine The risk or severity of hypertension can be increased when Periciazine is combined with Tinoridine.
Acepromazine The risk or severity of hypertension can be increased when Acepromazine is combined with Tinoridine.
Thioproperazine The risk or severity of hypertension can be increased when Thioproperazine is combined with Tinoridine.
Zuclopenthixol The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Tinoridine.
Epicaptopril The risk or severity of hypertension can be increased when Epicaptopril is combined with Tinoridine.
Clorgiline The risk or severity of hypertension can be increased when Clorgiline is combined with Tinoridine.
1-benzylimidazole The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Tinoridine.
Iproniazid The risk or severity of hypertension can be increased when Iproniazid is combined with Tinoridine.
Nialamide The risk or severity of hypertension can be increased when Nialamide is combined with Tinoridine.
Lysergic acid diethylamide The risk or severity of hypertension can be increased when Lysergic acid diethylamide is combined with Tinoridine.
Dronedarone The risk or severity of hypertension can be increased when Dronedarone is combined with Tinoridine.
Flibanserin The risk or severity of hypertension can be increased when Flibanserin is combined with Tinoridine.
Iloperidone The risk or severity of hypertension can be increased when Iloperidone is combined with Tinoridine.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul